SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scott_jiminez who wrote (4571)10/19/2000 11:25:18 AM
From: rkrw  Read Replies (1) of 10280
 
Scott---
You should consider a career as a class action attorney.
Seeing your postings of the past, it seems you derive perverse pleasure in other investors losses and, of course, the all consuming "I told you so" mentality. I don't like people like you.

I've been invested in Sepracor for 5+ years, added along the way and have held throughout. There's been major hiccups before no doubt they'll be more along the way.

Sepracor's strategy is not static. Its been shifting dramatically from outlicensing patents for royalties to taking select drugs and developing them internally. A look at the Sepracor pipeline highlights this. They have a handful of compounds under development, many approaching the point of high visibility that late stage products attract. Risks are buffered amongst 10-20 potential drug and royalty derived products. Rewards will come from exceeding expectations on prospective drug products. I expect the company to continue to add value and reward shareholders over the long term.

Take pleasure in this decline, document and point out your forewarnings, enjoy this moment, you deserve it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext